98%
921
2 minutes
20
Background And Objective: The purpose of this study was to analyze the safety and efficacy of combined intravitreal anti-vascular endothelial growth factor (anti-VEGF) and steroid therapeutic agents for resistant choroidal neovascularization (CNV). A retrospective observational clinical study was performed assessing anatomic and visual changes in a consecutive cohort of patients with refractory chronic wet age-related macular degeneration resistant to high-dose aflibercept therapy.
Patients And Methods: Twelve eyes of 12 patients with unresponsive CNV despite aggressive monthly anti-VEGF (4-mg aflibercept [mean: 43.75 ± SD23.08]) were included. Combination consisted of simultaneous administration of anti-VEGF and corticosteroids. Study measures evaluated visual acuity, central retinal thickness (CRT), and intraocular pressure.
Results: Paired tests revealed significant CRT reduction from the baseline at the 1-month (388.58 ± 89.31 versus 334.00 ± 92.88, = 0.0117), 2-month (388.58 ± 89.31 versus 312.08 ± 75.61, = 0.0185), and 3-month (388.53 ± 89.31 versus 304.56 ± 53.28, = 0.046) visit. The Kaplan-Meier curve showed a median time of remission (no retinal fluid) of 70 days (95% CI 53, 147 days).
Conclusion: Combination treatment demonstrated clear anatomic improvement in eyes with anti-VEGF-resistant CNV. .
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.3928/23258160-20240705-03 | DOI Listing |
Angew Chem Int Ed Engl
August 2025
Beijing Key Laboratory of Lignocellulosic Chemistry, State Key Laboratory of Efficient Production of Forest Resources, Beijing Forestry University, Beijing, 100083, P.R. China.
Electrocatalysis provides a green and sustainable approach for the upgrading of biomass-derived 5-hydroxymethylfurfural (HMF) to the polymer monomer 2,5-furandicarboxylic acid (FDCA). Precisely tuning the electronic structure, specifically the electron gradient orbitals and spin state of key active sites, is crucial for achieving high catalytic performance, as it directly influences the adsorption strength of the reactive substrate. Herein, by introducing Mn with low 3d filling, the e-e repulsion between bridging O and Ni is weakened due to π-donation function.
View Article and Find Full Text PDFJMIR Form Res
August 2025
Department of Behavioral and Policy Sciences, RAND Corporation, Santa Monica, CA, United States.
Background: Medication-assisted treatment (MAT) is an effective strategy for treating opioid use disorder and reducing opioid-related overdose deaths, yet retention in treatment remains low. Mobile health (mHealth) platforms may be a useful tool for increasing long-term engagement in MAT programs, but evaluation studies of such platforms are limited.
Objective: This study aimed to determine whether the use of the Opioid Addiction Recovery Support (OARS) software platform increased MAT engagement for patients with opioid use disorder.
Subst Use Misuse
July 2025
Department of Prevention and Community Health, Milken Institute School of Public Health, George Washington University, Washington, DC, USA.
Background: Since the 2018 Agricultural Improvement Act, derived intoxicating cannabis products (DICPs) emerged as largely unregulated products; meanwhile, traditional cannabis use has increased. To inform effective prevention, research is needed to assess differences in motives for using cannabis versus cannabis and DICPs, as well as use-related consequences.
Methods: We analyzed survey data (June-November 2023) from 4,031 US young adults ages 18-34 (average age = 26.
Purpose: We conducted a randomized controlled trial (SURF-RCT) to evaluate the efficacy of surgery versus radiofrequency ablation (RFA) for hepatocellular carcinoma (HCC). Simultaneously, eligible patients who dissented from random assignment were enrolled in a nonrandomized prospective observational trial (SURF-Cohort). We aimed to report the final analyses of overall survival (OS) and updated recurrence-free survival (RFS) in the SURF-RCT and SURF-Cohort trials.
View Article and Find Full Text PDFNeuro Oncol
March 2025
Department of Pediatric Medicine, Neuro-Oncology Division, St. Jude Children's Research Hospital.
Background: Brain tumor treatment can result in sensorineural hearing loss (SNHL) that is associated with cognitive declines in school-age children. Young children treated for brain tumors are at heightened cognitive risk. This study examines the unique contribution of treatment-related ototoxicity to cognitive outcomes in young children treated for brain tumors.
View Article and Find Full Text PDF